BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 25446728)

  • 1. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.
    Öhman L; Törnblom H; Simrén M
    Nat Rev Gastroenterol Hepatol; 2015 Jan; 12(1):36-49. PubMed ID: 25446728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal microbiota in functional bowel disorders: a Rome foundation report.
    Simrén M; Barbara G; Flint HJ; Spiegel BM; Spiller RC; Vanner S; Verdu EF; Whorwell PJ; Zoetendal EG;
    Gut; 2013 Jan; 62(1):159-76. PubMed ID: 22730468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota and intestinal immunity-A crosstalk in irritable bowel syndrome.
    Chen Y; Feng S; Li Y; Zhang C; Chao G; Zhang S
    Immunology; 2024 May; 172(1):1-20. PubMed ID: 38174581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity.
    Soderholm AT; Pedicord VA
    Immunology; 2019 Dec; 158(4):267-280. PubMed ID: 31509239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-immune cell crosstalk for intestinal barrier homeostasis.
    Yao Y; Shang W; Bao L; Peng Z; Wu C
    Eur J Immunol; 2024 Jun; 54(6):e2350631. PubMed ID: 38556632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irritable bowel syndrome: a clinical review.
    Chey WD; Kurlander J; Eswaran S
    JAMA; 2015 Mar; 313(9):949-58. PubMed ID: 25734736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota as potential orchestrators of irritable bowel syndrome.
    Bennet SM; Ohman L; Simren M
    Gut Liver; 2015 May; 9(3):318-31. PubMed ID: 25918261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena?
    Rajilić-Stojanović M; Jonkers DM; Salonen A; Hanevik K; Raes J; Jalanka J; de Vos WM; Manichanh C; Golic N; Enck P; Philippou E; Iraqi FA; Clarke G; Spiller RC; Penders J
    Am J Gastroenterol; 2015 Feb; 110(2):278-87. PubMed ID: 25623659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IBS: biomarkers for IBS: ready for prime time?
    Barbara G
    Nat Rev Gastroenterol Hepatol; 2015 Jan; 12(1):9-10. PubMed ID: 25446732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications.
    de Moreno de LeBlanc A; LeBlanc JG
    World J Gastroenterol; 2014 Nov; 20(44):16518-28. PubMed ID: 25469019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in the pathophysiology of irritable bowel syndrome.
    El-Salhy M
    World J Gastroenterol; 2015 Jul; 21(25):7621-36. PubMed ID: 26167065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress.
    Sundin J; Rangel I; Fuentes S; Heikamp-de Jong I; Hultgren-Hörnquist E; de Vos WM; Brummer RJ
    Aliment Pharmacol Ther; 2015 Feb; 41(4):342-51. PubMed ID: 25521822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota elicits a protective immune response against malaria transmission.
    Yilmaz B; Portugal S; Tran TM; Gozzelino R; Ramos S; Gomes J; Regalado A; Cowan PJ; d'Apice AJ; Chong AS; Doumbo OK; Traore B; Crompton PD; Silveira H; Soares MP
    Cell; 2014 Dec; 159(6):1277-89. PubMed ID: 25480293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and metabolic syndrome.
    Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
    World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut/brain axis and the microbiota.
    Mayer EA; Tillisch K; Gupta A
    J Clin Invest; 2015 Mar; 125(3):926-38. PubMed ID: 25689247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome.
    Moloney RD; Johnson AC; O'Mahony SM; Dinan TG; Greenwood-Van Meerveld B; Cryan JF
    CNS Neurosci Ther; 2016 Feb; 22(2):102-17. PubMed ID: 26662472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights on the human microbiome and its xenobiotic metabolism: what is known about its effects on human physiology?
    Tralau T; Sowada J; Luch A
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):411-25. PubMed ID: 25476418
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.